Medical Device | December 30, 2021
Siemens Healthineers receive EUA for Covid-19 antigen self-test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
The centre has an initial capacity of 500 FTEs
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
